WaveMan
WaveMan · Company
CBNK · Capital Bancorp Inc
> Search tickers & screens ⌘K
LIVE
← All companies

CBNK Capital Bancorp (CBNK) Insider Trading, Ownership & Congress Trades

Banks · National commercial banks · CIK 0001419536
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
69
13F, latest reported quarter
Conversions, 180 days
20
Codes C/M, not in net · $801.1K priced

Capital Bancorp insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for Capital Bancorp Inc in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Canuso Dominic C
SELL
2025-11-13 SECtraded 2025-11-12
3,400
$95.0K
+51.3%
Context
  • 15 earlier Form 4 trades (code P or S) here by this insider (15 buys), the last on Jul 31, 2025.
  • +15.1% median (+11.7% mean) 90-day return after 5 previous buys.
  • The trade is 237.1% of the 1,434 shares held after it.
  • No other insider sold within 30 days.
  • 69 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Canuso Dominic C sold about $95.0K of CBNK on Nov 12, 2025; 69 funds added in the latest 13F quarter.
Levitt Randall James
Director
SELL
2025-08-28 SECtraded 2025-08-27
37,338
$1.3M
+24.2%
Context
  • 6 earlier Form 4 trades (code P or S) here by this insider (4 buys, 2 sales), the last on Aug 26, 2025.
  • +12.7% median (+12.7% mean) 90-day return after 2 previous buys.
  • The trade is 62.2% of the 60,000 shares held after it.
  • No other insider sold within 30 days.
  • 69 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Levitt Randall James sold about $1.3M of CBNK on Aug 27, 2025, the largest insider sale at the company on our record; 69 funds added in the latest 13F quarter.
Levitt Randall James
Director
SELL
2025-08-28 SECtraded 2025-08-26
2,662
$91.6K
+24.2%
Context
  • 5 earlier Form 4 trades (code P or S) here by this insider (4 buys, 1 sale), the last on Feb 7, 2025.
  • +12.7% median (+12.7% mean) 90-day return after 2 previous buys.
  • The trade is 2.7% of the 97,338 shares held after it.
  • No other insider sold within 30 days.
  • 69 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Levitt Randall James sold about $91.6K of CBNK on Aug 26, 2025; 69 funds added in the latest 13F quarter.
Canuso Dominic C
EVP, Chief Financial Officer
BUY
2025-07-31 SEC
600
$18.7K
+37.1%
Context
  • 14 earlier Form 4 trades (code P or S) here by this insider (14 buys), the last on Mar 12, 2025.
  • +18.5% median (+17.4% mean) 90-day return after 4 previous buys.
  • The trade is 12.4% of the 4,834 shares held after it.
  • No other insider bought within 30 days.
  • 69 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, Chief Financial Officer Canuso Dominic C bought about $18.7K of CBNK on Jul 31, 2025; 69 funds added in the latest 13F quarter.
Suss Eric M.
EVP and CHRO
BUY
2025-06-12 SECtraded 2025-05-28
169
$5.6K
+34.2%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (1 buy, 1 sale), the last on Nov 21, 2024.
  • The trade is 0.3% of the 59,323 shares held after it.
  • 1 other insider bought within 30 days.
  • 69 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP and CHRO Suss Eric M. bought about $5.6K of CBNK on May 28, 2025; 1 other insider bought within 30 days and 69 funds added in the latest 13F quarter.
58 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 53 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
69 funds bought in last quarter
below 67% of Banks
Revenue
no revenue reported in any filing
Margin
no margin: no revenue reported
Buybacks
$3.6M repurchased, FY to 2026-06-30
below 58% of Banks
Short interest
6.2% of the float short (float per yahoo 2026-10-26) · 5.8 days to cover · settled 2026-09-30
more than 67% of Banks
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch CBNK

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+43.4%12M
-9%+8%+26%+44%2025-102025-122026-022026-042026-062026-082026-10 2025-11-12 · Canuso Dominic C sold $95.0K
Insider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns CBNK: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
786,588 sh
$27.6M
VANGUARD CAPITAL MANAGEMENT LLC
497,906 sh
$17.5M
DIMENSIONAL FUND ADVISORS LP
392,750 sh
$13.8M
ALLIANCEBERNSTEIN L.P.
439,426 sh
$13.1M
GEODE CAPITAL MANAGEMENT, LLC
298,500 sh
$10.5M

Congress trades in CBNK

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

CBNK planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

CBNK mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
BALLAST SMALL/MID CAP ETF
$4.9M position · as of 2026-06-30
2.7%
NORTH SQUARE KENNEDY MICROCAP FUND
$387.6K position · as of 2026-05-31
1.2%
GATOR CAPITAL LONG/SHORT FUND
$743.4K position · as of 2026-07-31
0.9%
Dunham Small Cap Value Fund
$740.0K position · as of 2026-07-31
0.8%
First Trust Dow Jones Select MicroCap Index Fund
$1.3M position · as of 2026-06-30
0.5%
Adara Smaller Companies Fund
$3.6M position · as of 2026-05-31
0.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$1.4M
$1.5M
$743.3K
+25%
n/a
2024
$1.6M
$1.3M
$671.4K
+25%
n/a
2023
$1.1M
$1.0M
$592.2K
+4%
n/a
2022
$1.1M
$834.5K
$681.8K
-9%
n/a
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 69 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
UMBFBWFGPBPEBOFMBMGABCNEWTPCBDCOMISBAWSBFJMSB

CBNK financials

Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
n/a
capex not filed for the four quarters
Debt to equity
n/a
no debt line filed
Cash flow to debt
n/a
no debt line filed
Return on equity
+14.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+1.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
no debt line filed
Return on capital employed
n/a
assets or current liabilities not filed
P/E, trailing
12.22x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
n/a
no debt line filed
FCF yield
n/a
capex not filed for the four quarters
PEG, trailing
0.43x
P/E over trailing EPS growth of 28%: four quarters to 2026-06-30 against the four to 2025-06-30
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Operating incomen/a-$3.7M-$4.6M-$4.5M
Net income$57.2M$31.0M$35.9M$41.8M
EPS (diluted)3.412.122.552.91
Operating cash flow$69.7M$34.9M$47.4M$51.4M
Buybacks$11.7M$1.4M$8.8M$0
Dividends paid$7.3M$5.3M$3.9M$3.1M
SEC XBRL, fiscal years, as known on 2026-10-28

CBNK Stock Sonar score 3/7 axes

Find similar shapesCompare

CBNK ranks highest on profitability (84th percentile) and institutional and government (33rd), and lowest on risk and compliance (17th), among Banks peers.

Profitability
84
Inputs
  • Return on equity+14.1% · 83 pct, sector of 327
  • Return on assets+1.5% · 86 pct, sector of 334
  • Return on invested capitalno debt line filed
  • Return on capital employedassets or current liabilities not filed
Institutional and government
33
Inputs
  • Funds adding, latest quarter69 · 33 pct, sector of 257
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
17
Inputs
  • Short interest, % of float+6.2% · 17 pct, sector of 378
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Financial health, Growth, Insider conviction, US patents
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies